July 24th 2023
Shared insight on the evolving state of renal cell carcinoma management and hope for future growth in the treatment landscape.
July 3rd 2023
Expert perspectives on the adverse event profiles of first-line combination therapies in the advanced clear cell renal cell carcinoma space.